It is Ridiculously Hard for Californians to get their DNA out of the FBI’s Genetic Database
By Kashmir Hill,
Fusion
| 12. 18. 2015
Untitled Document
In 2012, Silicon Valley millionaire Ravi Kumra was murdered during a home-invasion robbery. During the investigation of the crime scene, police found DNA under Kumra’s nails that seemed sure to belong to the person who had attacked him. When police checked the FBI genetic database, they found a match: Lukis Anderson, a homeless man previously convicted of a residential burglary. Anderson, who had suffered brain damage after being hit by a truck, denied murdering Kumra, but couldn’t remember where he’d been that night, so things were looking pretty bad for him.
But thanks to medical records, according to the San Jose Mercury News, Anderson’s lawyer was able to prove that his client was at a hospital that night; he’d passed out from drinking too much and been picked up by an ambulance—the same ambulance that later went to Kumra’s house. “His DNA turned up at the murder scene only because paramedics inadvertently transferred it there, via a simple oxygen-monitoring probe they’d clipped first onto his finger and then onto the dead man’s,” recounted the Mercury News last...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...